Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Gore

Showing results (61-70 of 157) with videos related to

Pageof 16
Sort By:
The British Journal of Radiology|April 1, 2009
Significance of tumour calcification in ovarian carcinomaG J C Burkill, S D Allen, R P A'hern, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1995
A phase II study of Tomudex in relapsed epithelial ovarian cancerM E Gore, H M Earl, J Cassidy, et al.
Bone Marrow Transplantation|December 1, 1989
VAMP followed by high dose melphalan and autologous bone marrow transplantation for multiple myelomaT J McElwain, M E Gore, M Meldrum, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Phase I study of carboplatin, doxorubicin and weekly paclitaxel in patients with advanced ovarian carcinomaV Hess, M W Verrill, C C Bomphray, et al.
Journal of Clinical Epidemiology|February 13, 2001
Therapy naivete in the era of potent antiretroviral therapyL P Jacobson, M E Gore, S A Strathdee, et al.
British Journal of Cancer|June 1, 1995
Platinum-Taxol non-cross resistance in epithelial ovarian cancerM E Gore, N Preston, R P A'Hern, et al.
Clinical and Experimental Dermatology|September 29, 2015
A mitogen-activated protein kinase kinase inhibitor induced compound skin toxicity with oedema in metastatic malignant melanomaC L Thomas, P S Mortimer, J M Larkin, et al.
British Journal of Cancer|October 1, 1995
Paclitaxel (Taxol) in relapsed and refractory ovarian cancer: the UK and Eire experienceM E Gore, V Levy, G Rustin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 9, 1998
Granulosa cell tumours of the ovary: demographics, survival and the management of advanced diseaseP Savage, D Constenla, C Fisher, et al.
Lancet (London, England)|January 18, 1992
Infectious complications of subcutaneous interleukin-2 and interferon-alphaA L Jones, I Cropley, M E O'Brien, et al.
Pageof 16

Showing results (61-70 of 157) with videos related to

Sort By:
Pageof 16
The British Journal of Radiology|April 1, 2009
Significance of tumour calcification in ovarian carcinomaG J C Burkill, S D Allen, R P A'hern, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1995
A phase II study of Tomudex in relapsed epithelial ovarian cancerM E Gore, H M Earl, J Cassidy, et al.
Bone Marrow Transplantation|December 1, 1989
VAMP followed by high dose melphalan and autologous bone marrow transplantation for multiple myelomaT J McElwain, M E Gore, M Meldrum, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Phase I study of carboplatin, doxorubicin and weekly paclitaxel in patients with advanced ovarian carcinomaV Hess, M W Verrill, C C Bomphray, et al.
Journal of Clinical Epidemiology|February 13, 2001
Therapy naivete in the era of potent antiretroviral therapyL P Jacobson, M E Gore, S A Strathdee, et al.
British Journal of Cancer|June 1, 1995
Platinum-Taxol non-cross resistance in epithelial ovarian cancerM E Gore, N Preston, R P A'Hern, et al.
Clinical and Experimental Dermatology|September 29, 2015
A mitogen-activated protein kinase kinase inhibitor induced compound skin toxicity with oedema in metastatic malignant melanomaC L Thomas, P S Mortimer, J M Larkin, et al.
British Journal of Cancer|October 1, 1995
Paclitaxel (Taxol) in relapsed and refractory ovarian cancer: the UK and Eire experienceM E Gore, V Levy, G Rustin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 9, 1998
Granulosa cell tumours of the ovary: demographics, survival and the management of advanced diseaseP Savage, D Constenla, C Fisher, et al.
Lancet (London, England)|January 18, 1992
Infectious complications of subcutaneous interleukin-2 and interferon-alphaA L Jones, I Cropley, M E O'Brien, et al.
Pageof 16